Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. (BPTH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bpth · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Bio-Path Holdings, Inc. (BPTH) measures how much investors pay for each dollar of the company's trailing earnings. BPTH's current PE ratio of N/A is calculated by dividing its stock price of $0.03 by its TTM earnings per share of -$0.65.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Bio-Path Holdings, Inc.You BPTH | $0M | N/A | — | -$0.65 |
 Elixinol Wellness Limited ELLXF | $1M | N/A | — | -$0.02 |
 Emmaus Life Sciences, Inc. EMMA | $1M | N/A | — | -$0.12 |
 Helix BioMedix, Inc. HXBM | $0M | N/A | — | -$2.45 |
 Indocan Resources Inc. IDCN | $0M | N/A | — | — |
 Orgenesis Inc. ORGS | $3M | N/A | — | -$1.91 |
 Paion AG PAIOF | $0M | N/A | — | -$0.08 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.10 | — | |
2024-12-31 FY2024 | — | $-4.12 | — | |
2023-12-31 FY2023 | — | $-33.64 | — | |
2022-12-31 FY2022 | — | $-38.03 | — | |
2021-12-31 FY2021 | — | $-31.04 | — | |
2020-12-31 FY2020 | — | $-56.44 | — | |
2019-12-31 FY2019 | — | $-64.02 | — | |
2018-12-31 FY2018 | — | $-287.54 | — | |
2017-12-31 FY2017 | — | $-278.69 | — | |
2016-12-31 FY2016 | — | $-291.26 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Bio-Path Holdings, Inc. (BPTH) measures how much investors pay for each dollar of the company's trailing earnings. BPTH's current PE ratio of N/A is calculated by dividing its stock price of $0.03 by its TTM earnings per share of -$0.65.
Frequently asked questions
BPTH pe ratio · 6 questionsBPTH's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.03 and TTM EPS of -$0.65. Data sourced from Financial Modeling Prep via BPTH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bio-Path Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09